[Risk factors of pulmonary cavitation in COVID-19 pneumonia].
Z G BerikkhanovSergey N AvdeevG V NekludovaE A TarabrinK R EminovaN N KhlistunovaPublished in: Khirurgiia (2024)
The risk of pulmonary cavitation in COVID-19 is directly related to advanced lung damage and untimely or absent biological therapy with IL-6 inhibitors. Pulmonary cavitation in COVID-19 is not a typical manifestation of disease and can be caused by some factors: fungal infection, secondary bacterial infection, tuberculosis and pulmonary infarction. Further study of this problem is required to develop diagnostic algorithms and treatment tactics.